| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.557 | 71.277 | 85.699 | 133.244 | 140.115 | 108.933 | 155.680 | 162.182 | 152.243 | 194.474 |
| Total Income - EUR | 55.557 | 71.277 | 85.699 | 133.244 | 148.165 | 118.138 | 155.717 | 162.182 | 152.243 | 194.474 |
| Total Expenses - EUR | 24.042 | 29.088 | 41.199 | 43.405 | 51.936 | 62.977 | 62.910 | 69.578 | 72.834 | 95.522 |
| Gross Profit/Loss - EUR | 31.515 | 42.189 | 44.500 | 89.839 | 96.229 | 55.161 | 92.807 | 92.604 | 79.409 | 98.951 |
| Net Profit/Loss - EUR | 29.849 | 41.477 | 43.643 | 88.510 | 94.747 | 54.260 | 91.437 | 91.015 | 77.917 | 93.234 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 |
Check the financial reports for the company - Oftaclinic Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.271 | 19.029 | 29.351 | 27.458 | 62.117 | 84.065 | 64.653 | 48.107 | 31.988 | 16.544 |
| Current Assets | 29.706 | 24.504 | 18.051 | 63.751 | 47.534 | 19.200 | 52.248 | 45.940 | 64.520 | 85.645 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 17.534 | 17.355 | 13.270 | 48.389 | 6.334 | 5.077 | 44.485 | 38.742 | 58.845 | 60.845 |
| Cash | 12.172 | 7.149 | 4.781 | 15.362 | 41.201 | 14.123 | 7.763 | 7.198 | 5.675 | 24.801 |
| Shareholders Funds | 32.363 | 42.000 | 44.158 | 88.852 | 95.083 | 64.846 | 114.414 | 91.338 | 78.239 | 93.554 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.614 | 1.573 | 3.244 | 2.440 | 14.569 | 38.632 | 2.673 | 2.905 | 18.479 | 8.822 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftaclinic Med Srl